These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 599731

  • 1. [A study of fibrinolytic therapy in glomerulonephritis and nephrotic syndrome. III. Indication, time to start therapy and criteria of effect (author's transl)].
    Sato M, Nakazora H, Ohfuji T.
    Nihon Jinzo Gakkai Shi; 1977 Sep; 19(9):717-31. PubMed ID: 599731
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H, Shibata M.
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract] [Full Text] [Related]

  • 3. [A study on the urokinase treatment in patients with glomerulonephritis and nephrotic syndrome].
    Konishi K, Kato E, Iyori S, Higashi F.
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):429-44. PubMed ID: 6750187
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of urokinase therapy in patients with glomerulonephritis and nephrotic syndrome. Trial at multiple institutes in Japan].
    Tomura S, Takeuchi J, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1984 Jan; 26(1):97-121. PubMed ID: 6376892
    [No Abstract] [Full Text] [Related]

  • 5. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T, Yokoyama S, Tanaka K, Haniu T, Suzuki T, Mithunami K, Takayama S, Oguma S, Hatori T, Kishimoto T, Tomimoto K.
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on blood coagulation and fibrinolytic activities in the cases of cerebral infarction treated with urokinase. 2nd Report -- espeically changes of coagulofibrinolytic system before and after UK infusion (author's transl)].
    Fujita S, Shou T, Yamamoto H, Ishikawa H, Itoga T.
    Rinsho Ketsueki; 1979 Jul; 20(7):745-53. PubMed ID: 501999
    [No Abstract] [Full Text] [Related]

  • 7. [Biochemistry and clinical significance of urokinase].
    Andrassy K, Ritz E.
    Dtsch Med Wochenschr; 1978 Jun 16; 103(24):1011, 1015-20. PubMed ID: 350536
    [No Abstract] [Full Text] [Related]

  • 8. [Urokinase (in situ) in the case of acute ischemia of the lower limbs (author's transl)].
    Paillot J, Dumontier P, Raynov M, Ott B, Benichoux R.
    J Mal Vasc; 1981 Jun 16; 6(1):19-22. PubMed ID: 7026712
    [Abstract] [Full Text] [Related]

  • 9. [Successful fibrinolytic treatment with urokinase six weeks after leg and pelvic vein thrombosis (author's transl)].
    Trübestein G, Etzel F, Sobbe A.
    Dtsch Med Wochenschr; 1974 Nov 29; 99(48):2457-9. PubMed ID: 4448142
    [No Abstract] [Full Text] [Related]

  • 10. [Thrombolytic therapy. Effect of urokinase on experimental thrombosis (author's transl)].
    Kakishita E.
    Rinsho Ketsueki; 1977 Jun 29; 18(6):719-25. PubMed ID: 916202
    [No Abstract] [Full Text] [Related]

  • 11. [Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
    Shibata M, Shimizu K, Kishi T, Kobayashi K, Sakai H, Sugiyama H, Oguri M.
    Nihon Jinzo Gakkai Shi; 1980 Sep 29; 22(9):1197-207. PubMed ID: 6450847
    [No Abstract] [Full Text] [Related]

  • 12. Is the hypotensive action of urokinase beneficial for thrombolytic therapy?
    Matsuo O, Kosugi T, Mihara H.
    Thromb Haemost; 1978 Apr 30; 39(2):526-7. PubMed ID: 580999
    [No Abstract] [Full Text] [Related]

  • 13. [Fibrinolytic treatment with urokinase in older phlebothrombosis (author's transl)].
    Trübestein G, Brecht T, Glänzer K, Koischwitz D, Etzel F.
    Med Klin; 1979 Sep 28; 74(39):1404-11. PubMed ID: 492059
    [Abstract] [Full Text] [Related]

  • 14. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
    Sakuragawa N.
    Nihon Naika Gakkai Zasshi; 1979 May 10; 68(5):486-9. PubMed ID: 469353
    [No Abstract] [Full Text] [Related]

  • 15. [Thrombolytic therapy using urokinase: its mechanism and clinical use (author's transl)].
    Sakuragawa N, Takahashi K.
    Rinsho Ketsueki; 1977 Jun 10; 18(6):726-31. PubMed ID: 916203
    [No Abstract] [Full Text] [Related]

  • 16. [Fibrinolytic treatment with urokinase of post acute phlebothromboses (author's transl)].
    Trübestein G, Brecht T, Etzel F.
    Dtsch Med Wochenschr; 1979 Aug 31; 104(35):1241-2. PubMed ID: 477521
    [Abstract] [Full Text] [Related]

  • 17. [Thrombolytic treatment with urokinase (author's transl)].
    Tilsner V, Greul W.
    MMW Munch Med Wochenschr; 1975 May 16; 117(20):865-8. PubMed ID: 124400
    [Abstract] [Full Text] [Related]

  • 18. [Urokinase therapy in diabetic retinopathy (author's transl)].
    Kojima K, Suzuki M, Ichikawa H, Ichikawa K, Torii F, Sato Y, Oguri T, Yamaguchi Y, Kobayashi M, Asanuma H.
    Nippon Ganka Gakkai Zasshi; 1981 Dec 10; 85(12):2108-14. PubMed ID: 7044071
    [No Abstract] [Full Text] [Related]

  • 19. [Thrombolysis with Urokinase after anaphylaxis caused by streptokinase treatment (author's transl)].
    Walter B, Tamm D.
    Med Klin; 1979 Feb 16; 74(7):239-41. PubMed ID: 763216
    [Abstract] [Full Text] [Related]

  • 20. Lytic therapy in vitreous haemorrhage.
    Forrester JV, Williamson J.
    Trans Ophthalmol Soc U K (1962); 1974 Jul 16; 94(2):583-6. PubMed ID: 4534194
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.